LONDON–(BUSINESS WIRE)– #GlobalPlanoSunglassesMarket–The plano sunglasses market will grow by USD 4.52 billion during 2020-2024, according to Technavio
Author: Business Wire
A Medical Laser Systems Company Enhanced Its Market Share by 37% Using Infiniti Research’s Market Penetration Strategy
LONDON–(BUSINESS WIRE)– #CompetitiveIntelligence–Infiniti Research has announced the completion of its latest success story on market penetration strategy for a medical laser systems client.
Glaukos Corporation Announces Fourth Quarter and Full Year 2019 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced finan…
IVERIC bio Reports Fourth Quarter and Year End 2019 Operational Highlights and Financial Results
NEW YORK–(BUSINESS WIRE)–IVERIC bio, Inc. announced financial and operating results for the fourth quarter and full year ended December 31, 2019 and provided a business update
Inflazome’s Somalix Demonstrates Positive Safety, Tolerability and Pharmacodynamic Profile in its Phase I Study
DUBLIN & CAMBRIDGE, United Kingdom & BRISBANE, Australia–(BUSINESS WIRE)–Inflazome (inflazome.com), the pioneering inflammasome biotech company developing multiple drugs that stop harmful inflammation, today announces the successful completion of a P…
Numerous Presentations to Showcase Long-Term Efficacy & Safety of Glaukos Technologies at 2020 American Glaucoma Society Meeting
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retina diseases, announced today that i…
STAAR Surgical Reports Fourth Quarter and Full Year 2019 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the fourth quarter and fi…
Texas-Based SmartHealth PayCard Offers Healthcare Providers and Millions of Americans Transformative Financial Solutions for Medical Expenses
DALLAS–(BUSINESS WIRE)–Texas-Based SmartHealth PayCard Offers Healthcare Providers and Millions of Americans Transformative Financial Solutions for Medical Expenses
IVERIC bio to Present at the Cowen and Company 40th Annual Health Care Conference
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced that Kourous A. Rezaei, M.D., CMO, will present at the Cowen and Company 40th Annual Health Care Conference.
Gemini Therapeutics and Singapore Eye Research Institute Enter Into Research Collaboration to Explore New Targets for Age-related Macular Degeneration
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gemini Therapeutics, a clinical stage precision medicine company developing innovative treatments for dry Age-related Macular Degeneration (AMD) and linked ocular disorders, today announced a collaboration with the Si…
Alcon Reports Full Year 2019 Results
GENEVA–(BUSINESS WIRE)–Alcon Reports Full Year 2019 Results
Outlook into the Global Optical Measurement Market to 2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Optical Measurement Market Analysis & Trends – Industry Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. The Global Optical Measurement Market is poised to grow strong during the for…
Ocular Therapeutix™ to Present at the Cowen and Company 40th Annual Health Care Conference
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
Aura Biosciences to Present at the Cowen 40th Annual Health Care Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a clinical-stage biopharmaceutical company developing a new class of tumor targeted therapies for initial application in primary tumors such as ocular and bladder cancers, today announced that Elisab…
Global Optical Biometry Devices Market 2019-2023 | Evolving Opportunities with Carl Zeiss Meditec AG and Menicon Co. Ltd. | Technavio
LONDON–(BUSINESS WIRE)– #GlobalOpticalBiometryDevicesMarket–The global optical biometry devices market is poised to grow by USD 83.77 million during 2019-2023
Aurinia Appoints Max Colao as Chief Commercial Officer and Expands U.S. Commercial Leadership Team
VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced th…
AIS Healthcare Acquires Ophthalmology Compounding Pharmacy Hunt Valley PharmaLAB
DALLAS–(BUSINESS WIRE)–AIS Healthcare has announced the acquisition of Hunt Valley PharmaLAB (“Hunt Valley”), a 503A compounding pharmacy focused on ophthalmology medications. Already the leading targeted drug delivery (TDD) and infusion care provide…
テジ・コーリ財団が2035年までの角膜失明排除を実現する新しいプロジェクトの育成を目指す
ロンドン–(BUSINESS WIRE)–（ビジネスワイヤ） — テジ・コーリ財団は、世界で角膜失明を排除する可能性を持つプロジェクトのシード資金を提供して資金調達を推進するための新しい事業育成制度を確立します。角膜失明の予防、治療、治癒に向けた明確な道筋を持つ商業プロジェクトと非商業プロジェクトの両方が、資金、実用的なリソース、知的資本を利用できるようになります。資金提供の決定は、医療サービスが不十分な世界の貧困地域社会で2035年までにプロジェクトが及ぼすであろう総合的な影響の重大性、およ…
Aldeyra Therapeutics to Provide Update on Late-Stage Clinical Development Pipeline at 2020 Research & Development Day
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today will host the 2020 Research & Development Day (R&D Day) with investors and financial analysts in New York City to present recent clinical development u…
Aerie Pharmaceuticals to Present at the Cowen 40th Annual Healthcare Conference
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…